Caroline Bradford

Comments of National Center for Health Research Regarding the USPSTF Draft Evidence Review: Screening for Depression and Suicide in Adults

October 17, 2022: We are concerned screening for asymptomatic depression and suicide has more risks than benefits. Further research is needed to find methods that accurately identify at-risk patients.

Comments of National Center for Health Research The USPSTF Draft Evidence Review: Screening for Anxiety in Adults

October 17, 2022: We are concerned the USPSTF recommended anxiety screening does not have enough supporting evidence, and the resulting treatments come with serious risks.

Liver Cancer: What is it and how to prevent it

This article explains the signs and symptoms of liver cancer and the steps you can take to prevent it. The best way to prevent it is to be tested for Hepatitis C, get vaccinated for Hepatitis B, and if diagnosed with either, get treated. Reducing smoking and alcohol consumption also helps prevent liver cancer.

Patient, Consumer, and Public Health Coalition Letter to Senate HELP and Energy and Commerce Committee Regarding User Fee Reauthorization Legislation

September 22, 2022: It is critically important that House and Senate committees work together to consolidate differences between the Food and Drug Amendments Act (H.R. 7667), which passed the House of Representatives on June 8, and the Food and Drug Administration Safety and Landmark Advancements Act (S. 4348), which passed the Senate Health, Education, Labor, and Pensions (HELP) Committee on June 15.

Comment of the National Center for Health Research Submitted to the EPA on the Designation of PFOA and PFOS as CERCLA Hazardous Substances, October 6, 2022

October 6, 2022: In our public comment to the EPA, the National Center for Health Research agrees with EPA’s proposed designation of PFOA and PFOS as CERCLA hazardous substances. Holding companies accountable for these toxic chemicals, and other PFAS chemicals, will improve human health.